Special thanks to the unit leaders for their strong support
Although there is evidence suggesting that DPP-4 inhibitors are less effective in patients with A1C 1% or who would benefit from weight loss, liraglutide is preferred because exenatide BID and EQW should not be used in such patients, but it should be used with caution [57]
Sarcopenia: Loss of muscle mass and strength, often seen with ageing or poor nutrition
Access to Specific Information and Data Portability Rights You have the right to request that we disclose certain information to you about our collection and use of your Personal Information collected on or after February 10, 2026
The science behind the triple agonist: GLP-1, GIP, and Glucagon Retatrutide (LY3437943) is a next-generation triple receptor agonist drug that activates three receptors (GLP-1, glucagon, and GIP receptors) simultaneously
The reason many people inject vitamin B12 for general health maintenance is because vitamin B12 helps the body perform so many of its crucial functions